Previous 10 | Next 10 |
Shares of healthcare company iRhythm Technologies (NASDAQ: IRTC) dropped by 16% in June after it announced that CEO Michael Coyle would be stepping down. Coyle will stay on with the company to assist in the leadership transition, but this was just the latest in a series of negat...
Palm Beach, FL – June 30, 2021 – Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and much research is devoted to this market. AF is responsible for most arrhythmia-related hospitalizations and leads to the greatest length of hospital stay associated w...
Gainers: BriaCell Therapeutics (BCTX) +91%.AMC Entertainment (AMC) +76%.Constellation Pharmaceuticals (CNST) +67%.Bed Bath & Beyond (BBBY) +45%.PetMed Express (PETS) +34%.Urban One (UONE) +31%.Vision Marine Technologies (VMAR) +28%.U.S. Well Services (USWS) +24%.Skillz (SKLZ)...
Gainers: BriaCell Therapeutics BCTX +151%, Constellation Pharmaceuticals CNST +67%, Soleno Therapeutics SLNO +46%, Stealth BioTherapeutics (MITO) +24%, Aerpio Pharmaceuticals (ARPO) +9%.Losers: iRhythm Technologies IRTC -18%, Progenity (P...
iRhythm cut to neutral at Citi on leadership transitionReaffirmed guidance for the current quarter did not help iRhythm Technologies (IRTC) to avert a sharp selloff in the post-market yesterday after announcing the departure of its CEO Michael Coyle effective June 01.The stock has e...
iRhythm Technologies (IRTC) -15% as CEO departs; Company reaffirms guidanceOrbital Energy Group (OEG) -13%.Protalix BioTherapeutics (PLX) -10% Protalix Biotherapeutics and Chiesi Global Rare Diseases provide update regarding clinical development of PRX-102 for treatment of fabr...
iRhythm Technologies (IRTC) has lost ~8.5% in the post-market after announcing the departure of company President/CEO Michael Coyle effective June 01 due to personal matters.Douglas Devine, the iRhythm’s chief financial officer has assumed the duties as interim CEO ...
President and CEO Michael Coyle Steps Down Due to Personal Matters Douglas Devine to Serve as Interim CEO While Search for Permanent CEO is Conducted SAN FRANCISCO, June 01, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions ...
SAN FRANCISCO, May 28, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 41 st Annual William Blair Growth Stoc...
iRhythm Technologies (IRTC) has received FDA’s 510K clearances for a new design of its flagship Zio monitor and its updated artificial intelligence ((AI)) capabilities.“iRhythm’s new Zio monitor and enhanced AI further illustrate our commitment to raising the st...
News, Short Squeeze, Breakout and More Instantly...
iRhythm Technologies Inc. Company Name:
IRTC Stock Symbol:
NASDAQ Market:
iRhythm Technologies Inc. Website:
SAN FRANCISCO, July 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2024 ...
2024-06-20 06:30:05 ET Wolfe Research analyst issues OUTPERFORM recommendation for IRTC on June 20, 2024 05:01AM ET. IRTC was trading at $98.16 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Strong B...
SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company has successfully launched the initial phases of it...